5Kamiya N, Akakura K, Suzuki H, et al. Pretreatrnent serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy [J]. Eur Urol, 2003, 44(3): 309-314.
6Fujii A, Kamiakito T, Takayashiki N, et al. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions[]J. Pathol Res Pract, 2003, 199(8): 513-519.
7Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors [J]. Endocr Rev, 2004, 25(3): 458-511.
8Eren F, Celikel C, Gulluoglu B. Neuroendocrine differentiation in gastric adenocarcinomas;correlation with tumor stage and expression of VEGF and p53[J]. Pathol Oncol Res, 2004, 10(1): 47-51.
9Naritomi K, Futami K, Arima S, et al. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma [J]. Anticancer Res, 2003, 23 (6a): 4411-4422
